EUVIMED · CrossrefZeitschrift
Trends in Cancer
ISSN 2405-8033 · Elsevier BV
Neueste Artikel
Neuron–tumor communication in solid tumors: from bona fide synapses to pseudo-synaptic neural interfaces
Evolution of mantle cell lymphoma therapy: advancing frontline precision
Immune cell metabolic reprogramming mediates ICI therapy resistance
Precision targeting of stromal states in pancreatic cancer: a clinical perspective
Prostate cancer: evading immunity, inspiring therapy
Cancer cell plasticity: new insights from developmental programs
Not ‘cold’ but conditional: emerging principles of immunotherapy in colorectal cancer
Lkb1 loss links dietary lipids to cancer cachexia
From fixed antibody–drug conjugates to programmable therapeutics
Acral melanoma: a unique subtype requiring unique solutions
Glioma–neuron interactions: from basics to therapy
Immune evasion in cancer dormancy and metastatic reactivation
IGF binding proteins: emerging endocrine mediators of cancer-associated muscle wasting
Advisory Board and Contents
Subscription & copyright page
Under pressure: clonal hematopoiesis in patients receiving cancer therapy
Navigating clinical decisions through cancer cartography
Exercise against cancer: recent advances and open questions
A roadmap for quantifying metabolism in patients with cancer
Accelerated aging and early-onset colorectal cancer
Trends at 50: a mission that matters
The impact of aging on antitumor immunity and cancer immunotherapy
Bioengineered systems to exploit tumor microenvironment metabolism
Deciphering tumor metabolites: emerging technologies shaping clinical implications
Gut microbial metabolites for potentiating cancer therapy
Amino acid metabolism at the senescence–cancer interface
Pseudomyxoma peritonei and the microbiome: Emerging observations and unanswered questions
Mitochondrial transfer reveals an organellar layer of cancer ecology
Exclusion of immune cells by vascular gates
A novel mechanism of autophagy-dependent immunosuppression in cancer?
EUVIMED